Expression of notch1 to -4 and their ligands in renal cell carcinoma: A tissue microarray study

Cancer Genomics and Proteomics

Volumn 8, Issue 2, 2011, Pages 93-101

  Anton Aparicio L M ^a,b,c,j   Medina Villaamil, Vanessa ^b   Aparicio Gallego, G ^b   Santamarina Cainzos I ^b   Garcia Campelo R ^c   Valbuena Rubira, L ^d   Vazquez Estevez S ^e,j   Leon Mateos L ^f,j   Firvida Perez, J L ^g,j   Ramos Vazquez M ^h,j   Fernandez Calvo O ^g,j   Victoria Bolos M ⁱ  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b CHU A Coruna   (Spain)

^c Medical Oncology Unit CHUAC SERGAS   (Spain)

^d Hospital HM Modelo   (Spain)

^e CH Xeral Calde   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g CHOU   (Spain)

^h NONE   (Spain)

ⁱ PFIZER INC   (United States)

^j GGIO GU   (Spain)

more..

Author keywords

Immunohistochemistry; Notch; Notch ligands; Renal cancer biomarkers; Tissue array

Indexed keywords

BIOLOGICAL MARKER; LIGAND; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL ANATOMY; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR LOCALIZATION;

EID: 79955045668     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Artavanis-Tsakonas S, Matsumo K and Fortini ME: Notch signaling. Science 268: 225-232, 1995.
2. Weinmaster G: The ins and outs of notch signaling. Mol Cel Neurosci 9: 91-102, 1997.
3. Radtke F and Raj K: The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3: 756-767, 2003.
4. Leimeister C, Schumaker N and Gessler M: Expression of Notch pathway genes in the embryonic mouse metanephros suggests a role in proximal tubule development. Gene Expr Patterns 3: 595-598, 2003.
5. Cheng HT and Kopan R: The role of Notch signaling in specification of podocyte and proximal tubules within the developing mouse kidney. Kidney Int 68: 1951-1952, 2005.
6. Challen GA, Bertancello I, Deane JA, Ricardo SD and Little MH: Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J Am Soc Nephrol 17: 1896-1912, 2006.
7. Hishikawa K and Fujita T: Kidney regeneration update. Nippon Rinsho 66: 941-947, 2008.
8. Sjölund J, Johansson M, Manna S, Norin C, Pietras A, Beckman S, Nilsson E, Ljungberg B and Axelson H: Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest 118: 217-228, 2008.
9. Rae FK, Stephenson SA, Nicol DL and Clements JA : Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display. Int J Cancer 88: 726-732, 2008.
10. Fuhrman SA, Lasky LC and Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655-663, 1982. (Pubitemid 13234762)
11. Miele L, Golde T and Osborne B: Notch signaling in cancer. Curr Mol Med 8: 905-918, 2006. (Pubitemid 44883940)
12. Allenspach EJ, Maillard I, Aster JC, Pear WS: Notch signaling in cancer. Cancer Biol Ther 5: 466-476, 2002.
13. Bolós V, Grego-Bessa J and de la Pompa JL: Notch signaling in development and cancer. Endocr Rev 28: 339-363, 2007.
14. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF and Wicha MS: Stem cells in normal breast development and breast cancer. Cell Prolif 36: 59-72, 2003. (Pubitemid 37521844)
15. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM and Wicha MS: Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 6: 605-615, 2004.
16. Van Es JH and Clevers H: Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol Med 11: 496-502, 2005. (Pubitemid 41653290)
17. Sancho E, Batlle E and Clevers H: Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 20: 695-723, 2004. (Pubitemid 39488655)
18. Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, Yoon K, Cook JM, Willert K, Gaiano N and Reya T: Integration of Notch and Wnt asignaling in hematopoietic stem cell maintenance. Nat Immunol 6: 314-322, 2005. (Pubitemid 41724769)
19. Aster JC: Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities. Int J Hematolo 82: 295-301, 2005.
20. Bolós V, Blanco M, Medina V, Aparicio G, Diaz-Prado S and Grande E: Notch signaling in cancer stem cells. Clin Transl Oncol 11: 11-19, 2009.
21. Weng AP, Ferrando AA, Lee W, Morris JP 4th, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT and Aster JC: Activating mutations of NOTCH1 in human T-cell acute lymphoblastic leukemia. Science 306: 269-271, 2004. (Pubitemid 39336870)
22. Lin YW, Nichols RA, Letterio JJ and Aplan PD: Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Blood 107: 2540-2543, 2006.
23. Sjölund J, Manetopoulos C, Stockhausen MT and Axelson H: The Notch pathway in cancer: differentiation gone awry. Eur J Cancer 41: 2620-2629, 2005. (Pubitemid 41607552)
24. Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB and Ball DW: Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 61: 3200-3205, 2001. (Pubitemid 32691976)
25. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M, Hui CC, Clevers H, Dotto GP and Radtke F: Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33: 416-421, 2003. (Pubitemid 36278861)
26. Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D, Brat DJ, Perry A and Eberhart CG: Notch1 and Notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 64: 7787-7793, 2004.
27. Dang L, Fan X, Chaudhry A, Wang M, Gaiano N and Eberhart CG: Notch3 signaling initiates choroid plexus tumor formation. Oncogene 25: 487-491, 2006. (Pubitemid 43117634)
28. Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, Maric D, Eberhart CG and Fine HA: Expression of Notch-1 and its ligands Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 65: 2353-2363, 2005. (Pubitemid 40490146)
29. Sun S, Du R, Gao J, Ning X, Xie H, Lin X, Liu J and Fan D: Expression and clinical significance of Notch receptors in human renal cell carcinoma. Pathology 41: 4335-4341, 2009.
30. Shi TP, Xu H, Wei JF, Ma X, Wang BJ, Ju ZH, Zhang GX, Wang C, Wu ZQ and Zhang X: Association of low expression of Notch-1 and Jagged-1 in human papillary bladder cancer and shorter survival. J Urol 180: 361-366, 2008.
31. Wang M, Xue L, Cao Q, Lin Y, Ding Y, Yang P and Che L: Expression of Notch1, Jagged 1 and beta-catenin and their clinicopathological significance in hepatocellular carcinoma. Neoplasma 56: 533-541, 2009.
32. Fiuza UM and Arias AM: Cell and molecular biology of Notch. J Endocrinol 194: 459-474, 2007.
33. Zolkiewska A: ADAM proteases: ligand processing and modulation of the Notch pathway. Cell Mol Life Sci 65(13): 2056-2068, 2008.
34. D'souza B, Miyamoto A and Weinmaster G: The many facets of Notch ligands. Oncogene 27: 5148-5167, 2008.
35. Hurlbut GD, Kankel MW, Lake RJ and Artavanis-Tsakonas S: Crossing paths with Notch in the hyper-network. Curr Opin Cell Biol 19: 166-175, 2008. (Pubitemid 46386408)
36. Roca C and Adams RH: Regulation of vascular morphogenesis by Notch signalling. Genes Dev 21: 2511-2424, 2007.
37. Sainson RC and Harris AL: Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies. Angiogenesis 11: 45-51, 2008.
38. Thurston G, Noguera-Troise I and Yancopoulos GD: The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat Rev Cancer 7: 327-331, 2007. (Pubitemid 46652486)
39. Yan M and Plowman GD: Delta-like4/Notch signalling and its therapeutic implications. Clin Cancer Res 13: 7243-7246, 2009.
40. Wang M, Wang J, Wang L, Wu L and Xin X: Notch1 expression correlates with tumor differentiation status in ovarian carcinoma. Med Oncol 27(4): 1329-1335, 2010.